The JAK/STAT signaling pathway plays a central role in regulating tumor cell proliferation, survival, immune evasion, and inflammatory responses [23,24,25].Aberrant activation of this pathway, particularly through STAT3, has been implicated in the pathogenesis and progression of ccRCC [26,27]. This evidence concerns the gene STAT3 and nonpapillary renal cell carcinoma.